Influence of time from admission to norepinephrine administration and volume of fluids received on outcomes of patients meeting sepsis-3 criteria: a retrospective study using the MIMIC-IV database

Objectives Vasopressors are a cornerstone in the management of sepsis, marked by distributive shock often unresponsive to fluid resuscitation. Prior research and clinician surveys have suggested that earlier usage of vasopressors corresponds to improved outcomes. Methods A retrospective cohort was constructed using patient data contained within the Medical Information Mart for Intensive Care-IV database. Analytic cohort included a total of 2079 patients meeting sepsis-3 criteria with a ≥2-point rise in Sequential Organ Failure Assessment score and administered norepinephrine (NE) as first-line vasopressor within 24 hours of admission to the intensive care unit (ICU). Patients receiving other vasopressors or missing documented fluid resuscitation information were excluded. Primary end points included mortality, use of invasive mechanical ventilation and length of stay which were analyzed in a multivariate logistic regression model for the primary effect of time from ICU admission to NE administration using covariates. Results Time to NE use was defined as either early, using <6 hours from time of ICU admission or late using >6 hours to ≤24 hours. Patients who received early NE had significantly lower adjusted odds of mortality (0.75, 95% CI 0.57 to 0.97, p=0.026), higher adjusted odds of invasive mechanical ventilation (1.48, 95% CI 1.01 to 2.16, p=0.045), no significant difference in hospital length of stay (difference in days 0.6 (95% CI −3.24 to 2.04)) and lower ICU length of stay (difference in days −0.9 (95% CI −1.74 to –0.01)), as compared with the late NE group. Conclusion Among patients admitted to the ICU for sepsis, early use of NE was associated with significantly lower odds of mortality but higher odds of mechanical ventilation, and no significant difference in length of hospital stay but less time in the ICU. Furthermore, the volume of fluids received prior to NE use may have a significant impact on optimal NE timing. Level of evidence Level IV—therapeutic care/management.

[1]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. , 2021, Critical care medicine.

[2]  E. Mao,et al.  Low fluid intake volume during the first 24 h and persistent negative fluid balance from the second day are associated with favorable prognosis for patients with sepsis , 2021, Experimental and therapeutic medicine.

[3]  B. Rochwerg,et al.  How I Do It: Dosing Fluids in Early Septic Shock. , 2020, Chest.

[4]  Dong Zhang,et al.  Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis , 2020, Critical Care.

[5]  A. Khanna,et al.  Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. , 2020, The Medical clinics of North America.

[6]  J. Teboul,et al.  Vasopressors in septic shock: which, when, and how much? , 2020, Annals of translational medicine.

[7]  J. Bakker,et al.  Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis , 2020, Critical Care.

[8]  V. Pavlov,et al.  Post-sepsis syndrome – an evolving entity that afflicts survivors of sepsis , 2019, Molecular Medicine.

[9]  M. Rech,et al.  Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. , 2019, Journal of critical care.

[10]  M. Soliman,et al.  Early Use of Norepinephrine Improves Survival in Septic Shock: Earlier than Early. , 2019, Archives of medical research.

[11]  C. Permpikul,et al.  Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial , 2019, American journal of respiratory and critical care medicine.

[12]  J. Vincent,et al.  Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit , 2018, Open forum infectious diseases.

[13]  E. Crouser,et al.  Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level* , 2018, Critical care medicine.

[14]  Mitchell M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 update , 2018, Intensive Care Medicine.

[15]  Stephen J. Huang,et al.  Association of Positive Fluid Balance and Mortality in Sepsis and Septic Shock in An Australian Cohort , 2017, Anaesthesia and intensive care.

[16]  P. Marik,et al.  A rational approach to fluid therapy in sepsis. , 2016, British journal of anaesthesia.

[17]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[18]  Derek Bell,et al.  Trial of early, goal-directed resuscitation for septic shock. , 2015, The New England journal of medicine.

[19]  Ognjen Gajic,et al.  Fluid Overload in Patients With Severe Sepsis and Septic Shock Treated With Early Goal-Directed Therapy Is Associated With Increased Acute Need for Fluid-Related Medical Interventions and Hospital Death , 2015, Shock.

[20]  P. Marik,et al.  Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. , 2014, Anaesthesiology intensive therapy.

[21]  Michael Bailey,et al.  Goal-directed resuscitation for patients with early septic shock. , 2014, The New England journal of medicine.

[22]  Stephen E. Lapinsky,et al.  Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock: A Multicenter, Observational Study* , 2014, Critical care medicine.

[23]  Hassane Njimi,et al.  Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. , 2014, The Lancet. Respiratory medicine.

[24]  Amber E Barnato,et al.  A randomized trial of protocol-based care for early septic shock. , 2014, The New England journal of medicine.

[25]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[26]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[27]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[28]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.